Kristi Kasprick, project manager of Real. Good. Northeast North Dakota, said three of the grant applications will assist in ...
STAAR study demonstrated positive mean annualized estimated glomerular filtration rate (eGFR) slope at 52-weeks across all dosed patients in the study, which U.S. Food and Drug Administration (FDA) ...
Melissa B. Davis uses CRISPR screening to better understand how cancer affects underrepresented populations and find new potential therapeutic targets.
Newco ALTx Therapeutics Ltd. has launched with a £12.55 million (US$17.1 million) seed round to develop inhibitors of the alternative lengthening of telomeres (ALT) pathway, by which 10% to 15% of ...
Researchers at City St. George’s, University of London, have identified a new molecular signature that may explain why ...
Laboratory signs of chronic kidney disease were greater for women who had a pregnancy complicated by preeclampsia, according to study data published in the Journal of the American Society of ...
The behaviour of a receptor protein can be influenced by the presence of certain lipids in the membrane it is embedded in.
The trial is conducted at the Mays Cancer Center, part of the University of Texas at San Antonio’s Health Science Center.
Sangamo Therapeutics recently reported detailed data from its completed registrational Phase 1/2 STAAR study of isaralgagene ...
The FDA is reviewing zanzalintinib combined with atezolizumab for metastatic colorectal cancer, with a PDUFA target date of December 3, 2026. The STELLAR-303 trial showed significant overall survival ...
Pharmaceutical Technology on MSN
CHMP grants positive opinion for J&J’s Akeega use
The CHMP decision is based on Phase III AMPLITUDE study results in 696 mHSPC patients.
Spain: In what could offer new hope for patients with pancreatic cancer, scientists at the Spanish National Cancer Research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results